Literature DB >> 11205599

A clinico-epidemiological study of organophosphorus poisoning at a rural-based teaching hospital in eastern Nepal.

P Karki1, S G Hansdak, S Bhandari, A Shukla, S Koirala.   

Abstract

Thirty-seven patients with severe organophosphorus poisoning (OPP) presented to the emergency ward of BP Koirala Institute of Health Sciences between January 1995 and December 1996. The mean age of patients was 26.9 years. There were 17 (46%) males and 20 (54%) females, with male:female ratio being 1:1.2.Twenty-three (62%) patients were unmarried with 16 (46%) of them students. The most common reason for poisoning was suicide--32 patients (86.5%). The most commonly involved compound was Metacid (methyl-parathion)--23 (62%) patients. Ninety per cent of the patients presented within 2 h of ingestion. All patients were managed with intravenous atropine. Pralidoxime was given to patients with nicotinic symptoms and mechanical ventilation initiated in patients with respiratory distress. The mean dose of atropine used in the first 24 h and during the hospital stay was 30.6 mg and 136.7 mg, respectively. The mean duration of treatment was 5.5 days (range 2-20 days). Two patients developed intermediate syndrome and the overall mortality among hospitalized patients was 8%.

Entities:  

Mesh:

Year:  2001        PMID: 11205599     DOI: 10.1177/004947550103100112

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  2 in total

1.  Efficacy of an organophosphorus hydrolase enzyme (OpdA) in human serum and minipig models of organophosphorus insecticide poisoning.

Authors:  Michael Eddleston; R Eddie Clutton; Matthew Taylor; Adrian Thompson; Franz Worek; Harald John; Horst Thiermann; Colin Scott
Journal:  Clin Toxicol (Phila)       Date:  2019-08-27       Impact factor: 4.467

2.  Suicide by pesticide ingestion in Nepal and the impact of pesticide regulation.

Authors:  Leah Utyasheva; Dilli Sharma; Rakesh Ghimire; Ayanthi Karunarathne; Gael Robertson; Michael Eddleston
Journal:  BMC Public Health       Date:  2021-06-14       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.